Skip to main content
Clinical Trials/NCT03151122
NCT03151122UnknownNot Applicable

The Effect of Nurse-led Continuous Support Program on Neurodevelopment of Preterm Infants and Psychological Well-being of the Parents: A Randomized Controlled Trial

Wuhan University0 sites140 target enrollmentStarted: August 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
140
Primary Endpoint
Infant neuro-development assessed by the Ages and Stages Questionnaire (ASQ)

Study Overview

Brief Summary

The objective of the study is to establish a continuous nurse-led integrated support program and to exam its impact on preterm infant neurodevelopment.

Research hypotheses include:1. The continuous nurse-led integrated support will have significant impact on preterm infant neurodevelopment; 2.The support program will also have positive effect on parent psychological well-being.

Detailed Description

The objective of the study is to establish the continuous nurse-led integrated support program as well as exam its impact on neurodevelopmental health of preterm infants.

Research hypotheses:

  1. Compared to control group, the preterm infants in the interventional group will experience significantly better performance on neuromotor, cognitive and social-emotional function at corrected age of 3 month;
  2. In comparison with those receiving routine support, parents receiving nurse-led continuous support will have significantly higher parental self-efficacy and exhibited better psychological well-being;
  3. Maternal parenting self-efficacy will mediate the relationship between nurse-led support and preterm infant neurodevelopment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
28 Weeks to 36 Weeks (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Preterm infants born between 28-36 weeks of gestation;
  • Parents residing in the same region for at least 5 years; .Parents agree to participate in the study.

Exclusion Criteria

  • infants with severe perinatal brain injury;
  • infant with congenital anomalies

Outcomes

Primary Outcomes

Infant neuro-development assessed by the Ages and Stages Questionnaire (ASQ)

Time Frame: infant neuro-development will be measured at 3 months of corrected age.

preterm infant will be assessed by the Ages and Stages Questionnaire (ASQ). The scale is used to help parent evaluate the development outcome of infants and young children by themselves.

Secondary Outcomes

  • Maternal psychological well-being(assess when infants reach 1 month of corrected age.)
  • Parental self-efficacy assessed by the Parenting Ladder Scale(assess when infants reach 3 month of corrected age)

Investigators

Sponsor
Wuhan University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jun Zhang

Associate Professor

Wuhan University

Similar Trials